Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Mitochonic acid 5 is an inhibitor of mitochondrial dysfunction.1 It increases intracellular ATP levels in Hep3B cells when used at a concentration of 3 µM. Mitochonic acid 5 (5 µM) rescues LPS-induced apoptosis and decreases in the mitochondrial membrane potential in BV-2 microglial cells.2 It protects against decreases in cell viability induced by L-buthionine-(S,R)-sulfoximine (BSO; Item No. 14484) in fibroblasts isolated from patients with various mitochondrial diseases, including Leigh syndrome and Leber’s hereditary optic neuropathy (EC50s = 2.3-5.1 µM), in an electron transport chain-independent manner.1 Mitochonic acid 5 (50 mg/kg) reduces plasma levels of creatinine and decreases acute renal tubular necrosis in a mouse model of bilateral retroperitoneal renal ischemia-reperfusion injury.3
WARNING This product is not for human or veterinary use.
1. Mitochonic acid 5 (MA-
2. Mitochonic acid 5 regulates mitofusin 2 to protect microglia. Neural Regen. Res. 16(9), 1813-1820 (2021).
3. Mitochonic acid 5 binds mitochondria and ameliorates renal tubular and cardiac myocyte damage. J. Am. Soc. Nephrol. 27(7), 1925-1932 (2016).